Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System.
Ali ZA, Dager A, Zúñiga M, Fonseca J, Arana C, Chamié D, Hill JM, Madder RD, Muller JE, Simonton CA, Tearney GJ, Stone GW. Ali ZA, et al. Among authors: fonseca j. J Soc Cardiovasc Angiogr Interv. 2024 Mar 5;3(4):101344. doi: 10.1016/j.jscai.2024.101344. eCollection 2024 Apr. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39130176 Free PMC article. No abstract available.
First in human evaluation of a novel Sirolimus-eluting ultra-high molecular weight bioresorbable scaffold: 9-, 24-and 36-months imaging and clinical results from the multi-center RENASCENT study.
Chieffo A, Khawaja SA, Vesga B, Hernandez H, Moncada M, Delgado JA, Esposito G, Ferrone M, Dager A, Arana C, Stabile E, Meliga E, De Benedictis M, Montorfano M, Latib A, Fonseca J, Gomez G, Tamburino C, Tarantini G, La Manna A, Maehara A, Granada JF, Colombo A. Chieffo A, et al. Among authors: fonseca j. Int J Cardiol. 2020 Dec 15;321:48-53. doi: 10.1016/j.ijcard.2020.08.014. Epub 2020 Aug 15. Int J Cardiol. 2020. PMID: 32810542
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.
Chieffo A, Khawaja SA, Latib A, Vesga B, Moncada M, Delgado JA, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada JF, Colombo A; Collaborators. Chieffo A, et al. Among authors: fonseca j. EuroIntervention. 2020 Jun 12;16(2):e133-e140. doi: 10.4244/EIJ-D-19-00600. EuroIntervention. 2020. PMID: 32149709 Free article. Clinical Trial.
Brazil's response to public health emergencies in 2023: lessons for the international community.
de Souza ASS, Cavalcante JR, Proença R, Frank CHM, Mendonça TB, Costacurta GF, de Assis Rodrigues I, da Fonseca JLP, de Freitas DRC, Filho EBB, Maciel ELN, de Oliveira Garcia MH. de Souza ASS, et al. Among authors: da fonseca jlp. Rev Panam Salud Publica. 2025 Jan 13;49:e15. doi: 10.26633/RPSP.2025.15. eCollection 2025. Rev Panam Salud Publica. 2025. PMID: 39811046 Free PMC article.
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study.
Shaharir SS, Nawi AM, Mariamutu TN, Kamaruzaman L, Said MSM, Rajalingham S, Parodis I, Sarkar M, Shinjo SK, Kadam E, Ziade N, Tan CL, Gullemin F, Caballero-Uribe CV, Tan AL, Andreoli L, Parihar J, Yaadav P, Saha S; COVAD Study Group; Gupta L, Agarwal V. Shaharir SS, et al. Int J Rheum Dis. 2025 Jan;28(1):e70043. doi: 10.1111/1756-185X.70043. Int J Rheum Dis. 2025. PMID: 39791506
1,824 results